Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -11.99EBITDA per Share
VS
Market
Sector
Industry
History
$ 2.86Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information
Ticker
XFORCompany Name
X4 PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQX4 PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XFOR - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -88.88M | $ -11.99 | 1 | 7.41M |
| 3/31/2025 | $ 26.84M | $ 3.92 | 1 | 6.84M |
| 12/31/2024 | $ -25.99M | $ -3.88 | 1 | 6.7M |
| 9/30/2024 | $ -6.16M | $ -0.92 | 1 | 6.7M |
| 6/30/2024 | $ 27.3M | $ 4.09 | 1 | 6.68M |
| 3/31/2024 | $ -120.35M | $ -18.05 | 1 | 6.67M |
| 12/31/2023 | $ -93.32M | $ -15.74 | 1 | 5.93M |
| 9/30/2023 | $ -104.02M | $ -15.84 | 1 | 6.57M |
| 6/30/2023 | $ -123.96M | $ -22.04 | 1 | 5.62M |
| 3/31/2023 | $ -89.72M | $ -18.44 | 1 | 4.87M |
Key Performance Insights, Last 5 Years
- X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -76.
- Over the past 5 years, X4 PHARMACEUTICALS INC's average EBITDAPS has been $ -41.83.
- The median EBITDAPS for X4 PHARMACEUTICALS INC during this period was $ -27.1
- X4 PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ 4.09.
- The lowest EBITDAPS recorded by X4 PHARMACEUTICALS INC in the same timeframe $ -96.87
X4 PHARMACEUTICALS INC's EBITDAPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDAPS Benchmarks
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for X4 PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -50.88M ] / (Shares WA [ 669.5K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -76 ] XFOR - EBITDA per Share, Last 5 years
$ -96.87
Minimum
Dec 31, 2021
$ 4.09
Maximum
Jun 30, 2024
$ -41.83
Average
$ -27.1
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |